#1
JOURNAL ARTICLE
Seth K Bechis, Alexander G Otsetov, Rongbin Ge, Zongwei Wang, Mark G Vangel, Chin-Lee Wu, Shahin Tabatabaei, Aria F Olumi
PURPOSE: In men with symptomatic benign prostatic hyperplasia 5α-reductase inhibitors are a main modality of treatment. More than 30% of men do not respond to the therapeutic effects of 5α-reductase inhibitors. We have found that a third of adult prostate samples do not express 5α-reductase type 2 secondary to epigenetic modifications. We evaluated whether 5α-reductase type 2 expression in benign prostatic hyperplasia specimens from symptomatic men was linked to methylation of the 5α-reductase type 2 gene promoter...
October 2015: Journal of Urology
#2
RANDOMIZED CONTROLLED TRIAL
Xiangyu Zhang, Xiaofang Zeng, Lini Dong, Xiaokun Zhao, Xiaobing Qu
PURPOSE: To evaluate the effects of simvastatin and atorvastatin in elderly male patients with benign prostatic hyperplasia (BPH) accompanied by metabolic syndrome (MetS). METHODS: Eligible patients aged >60 year with BPH accompanied by MetS were randomly assigned to receive 40 mg of simvastatin daily, 20 mg of atorvastatin daily or placebo (control group) treatment for 12 months. Serum lipids, interleukin 6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), prostate-specific antigen, prostate volume (PV) and the International Prostate Symptom Score (IPSS) were tested before and after treatment...
December 2015: World Journal of Urology
#3
JOURNAL ARTICLE
Ryan Pearson, Pamela M Williams
Benign prostatic hyperplasia (BPH) is a common condition that increases in prevalence with age. A history should include onset, duration, and severity of lower urinary tract symptoms and medication use to rule out other causes of symptoms. Physical examination includes a digital rectal examination and assessment for bladder distention or neurologic impairment. Recommended tests include serum prostate-specific antigen measurement and urinalysis to help identify infection, genitourinary cancer, or calculi as an alternative cause of lower urinary tract symptoms...
December 1, 2014: American Family Physician
#4
COMMENT
Steven A Kaplan
No abstract text is available yet for this article.
July 2014: Journal of Urology
1